We are pleased to announce that Jochen Daniel “Danny” Muehlschlegel has been named director of the Department of Anesthesiology and Critical Care Medicine, effective Sept. 1.

An innovative physician-leader, educator and translational researcher, Dr. Muehlschlegel joins us from Brigham and Women’s Hospital (BWH), where he is the vice chair of research, director of cardiac anesthesia research and the BWH Distinguished Chair of Anesthesiology, Perioperative and Pain Medicine.

Dr. Muehlschlegel investigates the impact of genetic variation on adverse cardiovascular events and their significance at a functional level. His NIH-funded work has led to more than 110 peer-reviewed publications. He is also the chief scientific officer of Team Heart, a nonprofit medical organization focused on bringing sustainable cardiac care to Rwanda.

Among Dr. Muehlschlegel’s many honors, he received the Kaplan Leadership Development Award from the Society of Cardiovascular Anesthesiologists, was elected to the Association of Cardiac Anesthesiologists and received the Distinction in Mentoring Award from Harvard Medical School. He is the chair of the Society of Cardiovascular Anesthesiologists Research Committee and a member of the leadership committee of the Cardiovascular Surgery and Anesthesia Council of the American Heart Association. Additionally, he is an oral board examiner of the American Board of Anesthesiology.

Dr. Muehlschlegel earned his medical degree from Albert Ludwig University of Freiburg, Germany, a Master of Medical Science degree in translational genetics from Harvard Medical School and a Master of Business Administration from the Massachusetts Institute of Technology Sloan School of Management. He completed his residency at the University of Florida, Gainesville, and fellowships in cardiac anesthesia and cardiovascular genetics at Brigham and Women’s Hospital and Harvard Medical School.

In addition, we would like to offer our deepest appreciation to Adam Sapirstein for his leadership of the department as the interim director for the past two years. Adam’s steadfast commitment to the department, school and Johns Hopkins Medicine has been unwavering throughout that period, and we are all very grateful.

Please join us in welcoming Dr. Muehlschlegel to Johns Hopkins.


Theodore L. DeWeese, M.D.
Interim Dean of the Medical Faculty
CEO, Johns Hopkins Medicine

Kevin W. Sowers, M.S.N., R.N., F.A.A.N.
President, Johns Hopkins Health System
EVP, Johns Hopkins Medicine